Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5536 to 5550 of 7681 results

  1. Risk tools to identify risk of developing COAG and risk of sight loss:- What is the predictive value of risk tools for identifying people in the community who are atincreased risk of developing chronic open angle glaucoma (COAG) and identifying people with COAG who are at increased risk of sight loss?

    Recommendation ID NG81/1 Question Risk tools to identify risk of developing COAG and risk of sight loss:- What is the predictive value

    Research recommendation
    Published
    18 October 2018

  2. Robust evidence is needed on the comparative performance of different faecal calprotectin tests, including the performance of POCTs compared with laboratory-based tests.

    Recommendation ID DG11/3 Question Robust evidence is needed on the comparative performance of different faecal calprotectin tests, including

    Research recommendation
    Published
    9 June 2015

  3. What is the effectiveness and cost effectiveness of routinely performing contrast-enhanced brain CT at the time of initial diagnosis and/or staging CT?

    Recommendation ID NG122/3 Question What is the effectiveness and cost effectiveness of routinely performing contrast-enhanced brain CT

    Research recommendation
    Published
    21 June 2019

  4. Routine outcome measurement:- In people with a common mental health disorder, what is the clinical utility of routine outcome measurement and is it cost effective compared with standard care?

    Recommendation ID CG123/4 Question Routine outcome measurement:- In people with a common mental health disorder, what is the clinical utility

    Research recommendation
    Published
    9 June 2015

  5. Safety and efficacy of antimuscarinics:- What is the safety and efficacy of more recently developed antimuscarinics compared with (a) placebo/usual care and (b) other antimuscarinics in the treatment of neurogenic lower urinary tract dysfunction?

    Recommendation ID CG148/1 Question Safety and efficacy of antimuscarinics:- What is the safety and efficacy of more recently developed

    Research recommendation
    Published
    9 June 2015

  6. Safety and efficacy of botulinum toxin:- What is the safety and efficacy of botulinum toxin compared with (a) usual care, (b) antimuscarinics and (c) augmentation cystoplasty in people with neurogenic lower urinary tract dysfunction?

    Recommendation ID CG148/2 Question Safety and efficacy of botulinum toxin:- What is the safety and efficacy of botulinum toxin compared

    Research recommendation
    Published
    9 June 2015

  7. Safety and safeguarding:- What safeguarding practices are most effective in improving outcomes for people using services?

    Recommendation ID NG21/5 Question Safety and safeguarding:- What safeguarding practices are most effective in improving outcomes for people

    Research recommendation
    Published
    13 October 2015

  8. Selective dorsal rhizotomy:- Does selective dorsal rhizotomy followed by intensive rehabilitation performed between the ages of 3 and 9 years in children who are at Gross Motor Function Classification System (GMFCS) level II or III result in good community mobility as a young adult?

    Recommendation ID CG145/5 Question Selective dorsal rhizotomy:- Does selective dorsal rhizotomy followed by intensive rehabilitation performed

    Research recommendation
    Published
    9 June 2015

  9. Selective internal radiation therapy for unresectable colorectal metastases in the liver

    Recommendation ID IPG672/1 Question Selective internal radiation therapy for unresectable colorectal metastases in the liver

    Research recommendation
    Published
    17 March 2020

  10. Saliva:- How is excessive drooling of saliva (sialorrhoea) managed in people with motor neurone disease (MND)?

    Recommendation ID NG42/4 Question Saliva:- How is excessive drooling of saliva (sialorrhoea) managed in people with motor neurone disease

    Research recommendation
    Published
    21 March 2016

  11. What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism?

    Recommendation ID NG145/11 Question What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism

    Research recommendation
    Published
    10 February 2020

  12. Screening assessment tools:- Develop reliable and valid screening assessment tools for attachment and sensitivity that can be made available and used in routine health, social care and education settings.

    Recommendation ID NG26/1 Question Screening assessment tools:- Develop reliable and valid screening assessment tools for attachment and

    Research recommendation
    Published
    11 December 2015

  13. Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities:- For adults with milder learning disabilities, what is the clinical and cost effectiveness of psychological interventions such as cognitive behavioural therapy (modified for people with learning disabilities) for treating depression and anxiety disorders?

    Recommendation ID NG54/3 Question Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning

    Research recommendation
    Published
    17 October 2016

  14. Pulmonary rehabilitation to improve outcomes in people with idiopathic pulmonary fibrosis:- Does pulmonary rehabilitation improve outcomes for people with idiopathic pulmonary fibrosis?

    Recommendation ID CG163/3 Question Pulmonary rehabilitation to improve outcomes in people with idiopathic pulmonary fibrosis:- Does pulmonary

    Research recommendation
    Published
    9 June 2015

  15. Psychological interventions to manage chronic headache disorders:- Does a psychological intervention such as cognitive behavioural therapy (CBT) improve headache outcomes and quality of life for people with chronic headache disorders?

    Recommendation ID CG150/4 Question Psychological interventions to manage chronic headache disorders:- Does a psychological intervention

    Research recommendation
    Published
    9 June 2015